Skip to main content
OpenTrials

Clinical trial condition

Polycythemia Vera

Explore clinical trials studying Polycythemia Vera. Study availability and eligibility vary by location and protocol.

118 public trials 26 recruiting studies
Refine in advanced search Browse all conditions

Polycythemia Vera trial results

Active, not recruiting

A Phase 3 Study of Rusfertide in Patients With Polycythemia Vera

NCT05210790

Conditions
Bone Marrow Diseases, Bone Marrow Neoplasms, Hematologic Diseases, +6 more
Locations
  • Infirmary Cancer Care Mobile, Alabama, United States
  • Palo Verde Hematology-Oncology Glendale, Arizona, United States
  • City of Hope Medical Center, Duarte Duarte, California, United States
  • California Cancer Associates for Research and Excellence - Fresno Fresno, California, United States
View all 184 locations
View Trial Details
Active, not recruiting

A Study to Access Efficacy and Safety of P1101 in Chinese PV Patients Who Are Intolerant or Resistance to HU

NCT05485948

Conditions
Bone Marrow Diseases, Bone Marrow Neoplasms, Hematologic Diseases, +6 more
Locations
  • Peking Union Medical College Hospital Beijing, China
  • Xiangya Hospital Central South University Changsha, China
  • The First Affiliated Hospital of Chongqing Medical Universit Chongqing, China
  • Nanfang Hospital affiliated to Southern Medical University Guangzhou, China
View all 14 locations
View Trial Details
Completed

A Study of Real-world Use and Effectiveness of Cytoreductive Strategies for the Treatment of Second-line Polycythemia Vera in France

NCT07839858

Conditions
Bone Marrow Diseases, Bone Marrow Neoplasms, Hematologic Diseases, +6 more
Locations
  • Novartis Investigative Site Bayonne, Bayonne Cedex, France
  • Novartis Investigative Site Saint Priest Jarez, Pays de la Loire Region, France
  • Novartis Investigative Site Aix-en-Provence, France
  • Novartis Investigative Site Amiens, France
View all 51 locations
View Trial Details
Completed

Myeloproliferative Neoplasms: an In-depth Case-control Study

NCT01831635

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +13 more
Locations
  • University Hospitals Southampton NHS Foundation Trust Southampton, England, United Kingdom
  • Belfast Health And Social Care Trust Belfast, Northern Ireland, United Kingdom
  • Queen's University Belfast Belfast, Northern Ireland, United Kingdom
View Trial Details
Completed

LOW-PV Continuation

NCT06752941

Conditions
Bone Marrow Diseases, Bone Marrow Neoplasms, Hematologic Diseases, +6 more
Locations
  • Fondazione IRCCS Policlinico San Matteo, Divisione Ematologia Pavia, Lombardy, Italy
  • Ospedale Borgo Roma, Divisione Ematologia Verona, Veneto, Italy
  • ASST Papa Giovanni XXIII, SC Ematologia Bergamo, Italy
  • Policlinico S. Orsola - Malpighi, UO Ematologia Bologna, Italy
View all 13 locations
View Trial Details
Completed

TGR-1202 + Ruxolitinib PMF PPV-MF PET-MF MDS/MPN Polycythemia Vera Resistant to Hydroxyurea

NCT02493530

Conditions
Bone Marrow Diseases, Bone Marrow Neoplasms, Hematologic Diseases, +8 more
Locations
  • Mayo Clinic - Arizona Phoenix, Arizona, United States
  • University of Colorado Cancer Center Aurora, Colorado, United States
  • Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States
  • Mays Cancer Center at University of Texas Health San Antonio San Antonio, Texas, United States
View Trial Details
Completed

A Study of Bomedemstat (IMG-7289/MK-3543) in Participants With Polycythemia Vera (IMG-7289-CTP-203/MK-3543-004)

NCT05558696

Conditions
Bone Marrow Diseases, Bone Marrow Neoplasms, Hematologic Diseases, +6 more
Locations
  • BRCR Global ( Site 0120) Plantation, Florida, United States
  • Hematology Oncology of the North Shore ( Site 0104) Skokie, Illinois, United States
  • University of Michigan Comprehensive Cancer Center ( Site 0008) Ann Arbor, Michigan, United States
  • Comprehensive Cancer Centers of Nevada - Peak ( Site 0118) Las Vegas, Nevada, United States
View all 17 locations
View Trial Details

Related conditions